Tvardi Therapeutics, Inc. short interest in 2025
In 2025, Tvardi Therapeutics, Inc.'s disclosed short interest ran from 1.61% of shares outstanding on 14 Mar 2025 to 6.74% on 31 Dec 2025, a change of +5.13 percentage points. The year's high was 12.54% on 15 Oct 2025 and its low 1.45% on 31 Mar 2025, averaging 7.25% across 13 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 30.41 days on 15 Sep 2025. Full history: Tvardi Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 1.61% (14 Mar 2025)
- End of year
- 6.74% (31 Dec 2025)
- Change
- +5.13 pp
- High
- 12.54% (15 Oct 2025)
- Low
- 1.45% (31 Mar 2025)
- Average
- 7.25%
- Highest days to cover
- 30.41 (15 Sep 2025)
- SEC filings marked
- 7
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Mar 2025 | 1.61% | 5.99 | 10-K filed |
| 31 Mar 2025 | 1.45% | 6.14 | |
| 15 Apr 2025 | 1.55% | 1.54 | |
| 15 Aug 2025 | 7.04% | 29.44 | 10-Q filed, results (8-K), 10-Q filed, results (8-K) |
| 29 Aug 2025 | 7.26% | 30.19 | |
| 15 Sep 2025 | 7.20% | 30.41 | |
| 30 Sep 2025 | 9.07% | 9.07 | |
| 15 Oct 2025 | 12.54% | 1.38 | |
| 31 Oct 2025 | 10.93% | 2.43 | |
| 14 Nov 2025 | 9.44% | 4.69 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 9.86% | 8.80 | |
| 15 Dec 2025 | 9.61% | 8.26 | |
| 31 Dec 2025 | 6.74% | 3.90 |
See also: Tvardi Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.